Table 3.

Intracellular ZDV-TP concentrations of HIV-infected patientsa

Patient no.Age (yrs)GenderbTime (h) between drug administration and blood samplingMean intracellular ZDV-TP concn ± SD (fmol/106 cells)c
135M2193 ± 4
252F4137 ± 1
339F1142 ± 1
438M1183 ± 16
543M12124 ± 4
666F1563 ± 4
  • a Patients were receiving the standard 300-mg ZDV dose twice daily.

  • b M, male; F, female.

  • c Intracellular concentrations are means of two measurements.